carboplatin,durvalumab,paclitaxel,olaparib,bevacizumab
astrazeneca,merck,roche
['olaparib', 'durva', 'duo-o', 'gyn', 'bevacizumab', 'ovarian']
 another practice-changing study at #asco23 duo-o/ 3025 demonstrates improved progression free survival in pts w/ hr deficient and proficient advanced stage #ovariancancer treated with durvalumab + olaparib + bevacizumab #gyncsm #immunoonc 
Gyn Onc at MD Anderson. She/Hers. Wife of @DrJasonWestin. Innovative clinical trials. @ASCO_JCO social media editor. Opinions=mine.
https://t.co/QLXLDKSThc